Executive Name] c/o Sarepta Therapeutics, Inc. Cambridge, MA 02142 Dear [______]:Sarepta Therapeutics, Inc. • May 8th, 2019 • Pharmaceutical preparations • Massachusetts
We are pleased to confirm our agreement relating to your continued employment with Sarepta Therapeutics, Inc. (the “Company”) pursuant to the terms and conditions as set forth in this letter agreement (this “letter agreement”). Defined terms that are used but not defined herein shall have the meanings given to such terms as shown on Annex A. All payments and benefits payable pursuant to this letter agreement will be subject to applicable withholding taxes. This letter agreement replaces and supersedes any prior employment agreement or other letter agreement providing for severance payments or benefits (“Prior Agreement”), other than the Change in Control Severance Agreement dated as of the same date written above and entered into simultaneously with this letter agreement (the “CIC Severance Agreement”).
SAREPTA THERAPEUTICS, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • May 8th, 2019 • Sarepta Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Change in Control and Severance Agreement (the "Agreement") is made and entered into by and between [●] (the "Executive") and Sarepta Therapeutics, Inc. (the "Company"), effective as of the latest date set forth by the signatures of the parties hereto below (the "Effective Date").
